Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2025-12-16 @ 8:11 PM
Study NCT ID:
NCT06306560
Status:
None
Last Update Posted:
2024-03-12 00:00:00
First Post:
2024-02-29 00:00:00
Brief Title:
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Sponsor:
Harbin Medical University
Organization:
Harbin Medical University
Organization Data
Organization:
Harbin Medical University
Class:
OTHER
Study ID:
MA-SCLC-II-018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Harbin Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Yanbin Zhao
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Harbin Medical University
Old Name:
None
Old Organization:
None